Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Optiscan ImagingASX:OIL 22 Altman Z-Score is 20.14 as of Aug. 04, 2026. GuruFocus rates ASX:OIL with a GF Score™ of 22/100 and a GF Value™ of A$0.04 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 2,458 Hardware companies, Optiscan Imaging ranks better than 95.89% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 23.44 is strong.
Optiscan Imaging has a Altman Z-Score of 20.14, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Optiscan Imaging's Altman Z-Score or its related term are showing as below:
ASX:OIL'
s Altman Z-Score Range Over the Past 10 Years
Min: -41.45 Med: -2.47 Max: 59.93
Current: 23.44
During the past 13 years, Optiscan Imaging's highest Altman Z-Score was 59.93. The lowest was -41.45. And the median was -2.47.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Optiscan Imaging Altman Z-Score Related Terms
Optiscan Imaging Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Optiscan Imaging's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:OIL vs COHR, KEYS, GRMN: Altman Z-Score Comparison
For the Scientific & Technical Instruments subindustry, Optiscan Imaging's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optiscan Imaging Altman Z-Score vs Hardware Industry
For the Hardware industry and Technology sector, Optiscan Imaging's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Optiscan Imaging's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Optiscan Imaging's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.6968
+
1.4
*
-7.7031
+
3.3
*
-0.5937
+
0.6
*
53.2557
+
1.0
*
0.0902
=
20.14
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Optiscan Imaging (ASX:OIL) has a Altman Z-Score of 20.14 as of Aug. 04, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Optiscan Imaging and its competitors. According to the industry distribution chart, Optiscan Imaging ranks #101 out of 2458 companies in the Hardware industry, placing it in the top 4.1%.
Is Optiscan Imaging's Altman Z-Score too high?
Optiscan Imaging's current Altman Z-Score is 20.14. The Hardware industry median Altman Z-Score is 3.34. Optiscan Imaging's value of 20.14 is 503% above this industry median. Based on the distribution chart, Optiscan Imaging ranks #101 out of 2458 companies in the Hardware industry, which is in the top quartile — a strong position relative to peers. Overall, Optiscan Imaging has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Optiscan Imaging's Altman Z-Score compare to COHR and KEYS?
According to the Hardware industry distribution chart, Optiscan Imaging ranks #101 out of 2458 companies for Altman Z-Score. This places Optiscan Imaging in the top 4% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 3.34. Optiscan Imaging's value of 20.14 is 503% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Hardware company?
The median Altman Z-Score among Hardware companies is 3.34, based on 2,458 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Optiscan Imaging's current Altman Z-Score of 20.14 is 503% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Optiscan Imaging and its competitors. For the Hardware industry, the median Altman Z-Score is 3.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optiscan Imaging's current Altman Z-Score is 20.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optiscan Imaging stock overvalued right now?
Based on GuruFocus' analysis, Optiscan Imaging (ASX:OIL) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.04, compared to a current price of A$0.15 — trading 262.5% above its estimated fair value. The current Altman Z-Score is 20.14 and 503% above the Hardware industry median of 3.34. Optiscan Imaging's overall GF Score™ is 22/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Optiscan Imaging (ASX:OIL), the current Altman Z-Score is 20.14 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Optiscan Imaging (ASX:OIL) Overvalued in 2026?
Based on GuruFocus' analysis, Optiscan Imaging stock appears to be overvalued.
The current stock price of A$0.15 is trading 262.5% above its estimated GF Value™ of A$0.04.
GuruFocus considers Optiscan Imaging to be Significantly Overvalued.
Key valuation signals for ASX:OIL:
Altman Z-Score: 20.14
GF Value™: A$0.04 vs. price of A$0.15 (262.5% above fair value)
Industry Position: 503% above the Hardware median (#101 of 2458)
No single metric tells the full story. See the ASX:OIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Optiscan Imaging Ltd is engaged in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications. Its technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions. Its products include InVivage, ViewnVivo, and Customisation. Its geographical segments include Australia, Germany, Norway, China, and the United States.
22GF Score
Get the complete analysis for ASX:OIL
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:OIL has been successfully added to your 
